Have you ever noticed an inverted black triangle 
in the prescribing information of certain medicines?
In the European Union, this symbol indicates that a medicine is under additional monitoring. It does not mean that the medicine is unsafe. Instead, it signifies that regulatory authorities are actively encouraging the reporting of suspected adverse drug reactions ( ADRs) to gather more information.
A medicine may be placed under additional monitoring if :
- It contains a new active substance.
- It is a newly authorized biological product, such as vaccine.
- It has received conditional approval or approval under exceptional circumstances.
- Additional post-authorization safety studies are required.
- Enhanced safety monitoring has been mandated by regulatory authorities.
A medicine’s safety evaluation does not end at approval – it continues throughout its lifecycle.
Have you encountered the symbol before? What are your thoughts on the role of additional monitoring in strengthening pharmacovigilance systems?
Source article : Medicines under additional monitoring | European Medicines Agency (EMA)